Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (November 16th, 2019)
A weekly review of only the most important cannabis news to impact your marijuana stocks portfolio. #marijuanastocks #potstocks Read the full article

seen from Brazil

seen from United States

seen from United States

seen from Netherlands

seen from United States
seen from China
seen from Türkiye
seen from United States
seen from United Kingdom
seen from Türkiye

seen from United States
seen from China

seen from Brazil
seen from China
seen from Brazil

seen from United Kingdom
seen from Germany
seen from United States

seen from Austria

seen from Germany
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (November 16th, 2019)
A weekly review of only the most important cannabis news to impact your marijuana stocks portfolio. #marijuanastocks #potstocks Read the full article
InvestorPlace: Canopy Growth Stock Likely Gets Worse Before it Gets Better, But That’s Okay
InvestorPlace: Canopy Growth Stock Likely Gets Worse Before it Gets Better, But That’s Okay
In the world of cannabis equities, nothing seems to be working these days, a sentiment that extends to Canopy Growth (NYSE:CGC) stock. Shares of the Canadian pot producer are down nearly 19% year-to-date, but the bad news doesn’t end there. Far from. As of Oct. 1, CGC stock sat more than 63% below its 52-week high.
Source: Jarretera / Shutterstock.com
Said another way, when applying the strict…
View On WordPress
InvestorPlace: In Battered Cannabis Space, Aphria Stock May Be Worth a Look
InvestorPlace: In Battered Cannabis Space, Aphria Stock May Be Worth a Look
Aphria (NYSE:APHA) stock rose nicely last month. After falling to as low as $5.02/share, Aphria stock rallied in early August on strong earnings. APHA has since declined from $7.45/share to around $6.95/share.
At its current valuation, APHA stock trades at a discount to Aurora Cannabis (NYSE:ACB) and Canopy Growth (NYSE:CGC). But does this make Aphria stock a value play? APHA has a tarnished…
View On WordPress
InvestorPlace: Why Cronos Group Stock Stands Out in a Sea of Cannabis Sameness
InvestorPlace: Why Cronos Group Stock Stands Out in a Sea of Cannabis Sameness
Cronos Group (NASDAQ:CRON) in late July announced the purchase of four subsidiaries of Redwood Holding Group. Like other recent acquisitions, the Redwood buy demonstrates how Cronos is taking a distinctly different path to growth than its major competitors. This difference, though, is not reflected in CRON stock at the moment.
Source: Shutterstock
In its last earnings period, Cronos Group…
View On WordPress
InvestorPlace: Is Hexo Stock a Falling Knife Or Has It Reached a Good Entry Point?
InvestorPlace: Is Hexo Stock a Falling Knife Or Has It Reached a Good Entry Point?
The recent market drop has certainly been brutal and quite broad. But then again, this bear move is opening up interesting opportunities.
Just look at the cannabis space. In fact, the downturn of marijuana stocks preceded the recent decline of the overall markets, as various public cannabis companies had a tough time meeting investors’ lofty expectations.
In yesterday’s trading, Canopy Growth(NY…
View On WordPress
InvestorPlace: Stock Market Today: GE, Cisco and Canopy Make Wild Moves
InvestorPlace: Stock Market Today: GE, Cisco and Canopy Make Wild Moves
It’s no shocker, but Thursday has been another volatile trading session. Following Wednesday’s action — where the Dow Jones Industrial Average fell 800 points and the Nasdaq Composite tumbled 3% — it was a mixed session in the stock market today. It wasn’t exactly the rebound that bulls were hoping to muster given the massive declines experienced a day prior.
The stock market got off to a quick…
View On WordPress
InvestorPlace: Why I Have High Expectations for Canopy Growth Stock When it comes to cannabis stocks, Canopy Growth Corp (NYSE:CGC) stock investors consider it the 800-pound gorilla in the room: a force to be reckoned with, and a destroyer of competitors as well as short-sellers.
InvestorPlace: Should You Buy Hexo Stock? 3 Pros, 3 Cons
InvestorPlace: Should You Buy Hexo Stock? 3 Pros, 3 Cons
The marijuana market has created an appealing opportunity for risk-tolerant investors who are willing to wait out the near-term turbulence. However, while deciding to invest in the cannabis boom might seem like a no-brainer, choosing a winner in the space takes a bit more analysis. Recently, Canadian marijuana firm Hexo Corp (NYSE:HEXO) has gained a lot of attention and made many traders’ short…
View On WordPress